CompletedNCT06147622
Pharmacokinetic Profile of Prazosin and Cyproheptadine
This study is completed in France. It focuses on Addiction.
In GièresAddictionDrugA study involving a medication or substance.From 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT01559272
Safety study of pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in schizophrenia
This study is completed in the United States, in Belgium, in Bulgaria, .... It is testing pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate for schizophrenia.
Multiple locations, including Little RockSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT02935725
PharmacoMRI Effects of AUT00206 in Healthy Males
This study is completed in the United Kingdom. It is testing pharmacoMRI Effects of AUT00206 for Schizophrenia.
In LondonSchizophreniaDrugFrom 18 Years to 45 Years
CompletedNCT02712463
Rate of Hospitalization in people with Schizophrenia Treated With Antipsychotics
This study is completed in Brazil and in Mexico. It is testing rate of Hospitalization for schizophrenia.
Multiple locations, including AracajuSchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT01530529
Relative Bioavailability of a Modified-Release Formulation of PF-05180999
This study is completed in the United States. It focuses on Schizophrenia.
In New HavenSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT05059600
Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
This study is completed in the United States. It is testing Safe-Use Conditions for Depression.
Multiple locations, including Culver CityDepressionDrugOver 18 Years
CompletedNCT03557931
Safety and Efficacy of ASP4345 for schizophrenia
This study is completed in the United States. It is testing Safety and Efficacy of ASP4345 for schizophrenia.
Multiple locations, including CerritosSchizophreniaDrugFrom 18 Years to 55 Years
WithdrawnNCT05062577
Safety study of Safety and Efficacy of ASP8062 in Addiction
This study was withdrawn. It is testing Safety and Efficacy of ASP8062 for Addiction.
Location not clearly listedAddictionDrugFrom 18 Years to 65 Years
CompletedNCT06979544
Safety study of Safety and Efficacy of Oral LPCN 1154A in Depression
This study is completed in the United States. It is testing Safety and Efficacy of Oral LPCN 1154A for Depression.
Multiple locations, including AnahiemDepressionDrugFrom 15 Years to 45 Years
CompletedNCT03665038
Brexanolone for depression
This study is completed in the United States. It is testing brexanolone for depression.
Multiple locations, including TempeDepressionDrugFrom 15 Years to 17 Years
CompletedNCT03818256
Safety study of safety, Efficacy, and Pharmacokinetics of Miricorilant in schizophrenia
This study is completed in the United States. It is testing safety, Efficacy, and Pharmacokinetics of Miricorilant for schizophrenia.
Multiple locations, including BentonvilleBipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT00812058
Safety study of Safety, Tolerability and Efficacy of RG2417 in depression
This study is completed in the United States. It is testing Safety, Tolerability and Efficacy of RG2417 for depression.
Multiple locations, including BirminghamBipolarity, DepressionDrugFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.